Mthfd1l(Methylenetetrahydrofolate dehydrogenase [NADP+] 1-like)是一种线粒体酶,参与一碳代谢途径,催化10-甲酰四氢叶酸(10-formyl-tetrahydrofolate)生成甲酸盐,从而为一碳单位提供来源。这些一碳单位在细胞核苷酸合成、氨基酸互变、甲基供体生成和氧化还原辅因子的再生等细胞过程中发挥着重要作用。Mthfd1l的缺失会导致胚胎致死、发育迟缓和神经管缺陷[1]。
在一项研究中,研究人员通过分析Mthfd1l基因敲除胚胎的神经组织,发现Mthfd1l缺失会导致颅部间充质细胞密度显著降低,这可能是由于线粒体产生的一碳代谢物不足导致的。此外,研究人员还发现,补充甲酸盐可以改善Mthfd1l基因敲除胚胎的颅部间充质细胞密度和细胞增殖[1]。
另一项研究表明,Mthfd1l基因的rs11754661多态性与中国汉族人群的阿尔茨海默病(Alzheimer's disease, AD)易感性相关。携带Mthfd1l基因rs11754661多态性A等位基因的个体,患AD的风险显著增加[2]。然而,在西班牙人群中进行的研究并未发现Mthfd1l基因rs11754661多态性与AD易感性之间的关联[4]。
Mthfd1l基因的rs6922269多态性与心血管疾病风险相关。在捷克男性急性冠状动脉综合征(Acute Coronary Syndrome, ACS)患者中,携带Mthfd1l基因rs6922269 AA基因型的个体,心血管死亡率显著升高[7]。此外,Mthfd1l基因rs6922269多态性还与华法林治疗期间的敏感性相关,影响华法林剂量和治疗效果[3]。
Mthfd1l基因的缺失还会影响细胞代谢过程,如糖酵解和三羧酸循环。研究发现,Mthfd1l基因敲除胚胎的糖酵解和三羧酸循环代谢途径受到干扰,导致细胞生长和发育异常。而补充甲酸盐可以部分纠正这些代谢紊乱[6]。
此外,Mthfd1l基因的敲低可以抑制甲状腺癌细胞的生长并诱导细胞凋亡。研究还发现,Mthfd1l基因敲低后,甲状腺癌细胞中Notch2、CCND1、Bcl-2和PCNA蛋白的表达水平下调,而Bax蛋白的表达水平上调,表明Mthfd1l基因可能作为甲状腺癌的潜在治疗靶点[5]。
综上所述,Mthfd1l基因在胚胎发育、神经管形成、心血管疾病、阿尔茨海默病和甲状腺癌等多种生物学过程中发挥重要作用。Mthfd1l基因的缺失或突变可能导致细胞代谢紊乱、发育异常和疾病发生。进一步研究Mthfd1l基因的功能和调控机制,有助于深入理解其生物学作用和疾病发生机制,为相关疾病的治疗和预防提供新的思路和策略。
参考文献:
1. Shin, Minhye, Vaughn, Amanda, Momb, Jessica, Appling, Dean R. 2019. Deletion of neural tube defect-associated gene Mthfd1l causes reduced cranial mesenchyme density. In Birth defects research, 111, 1520-1534. doi:10.1002/bdr2.1591. https://pubmed.ncbi.nlm.nih.gov/31518072/
2. Ren, Ru-Jing, Wang, Li-Ling, Fang, Rong, Wang, Gang, Chen, Sheng-Di. 2011. The MTHFD1L gene rs11754661 marker is associated with susceptibility to Alzheimer's disease in the Chinese Han population. In Journal of the neurological sciences, 308, 32-4. doi:10.1016/j.jns.2011.06.036. https://pubmed.ncbi.nlm.nih.gov/21741665/
3. Al-Eitan, Laith N, Almasri, Ayah Y, Khasawneh, Rame H, Alghamdi, Mansour A. 2020. Influence of SH2B3, MTHFD1L, GGCX, and ITGB3 Gene Polymorphisms on theVariability on Warfarin Dosage Requirements and Susceptibility to CVD in the Jordanian Population. In Journal of personalized medicine, 10, . doi:10.3390/jpm10030117. https://pubmed.ncbi.nlm.nih.gov/32916786/
4. Ramírez-Lorca, Reposo, Boada, Mercé, Antúnez, Carmen, Real, Luis M, Ruiz, Agustín. . The MTHFD1L gene rs11754661 marker is not associated with Alzheimer's disease in a sample of the Spanish population. In Journal of Alzheimer's disease : JAD, 25, 47-50. doi:10.3233/JAD-2011-101983. https://pubmed.ncbi.nlm.nih.gov/21383495/
5. Yi, Dandan, Yilihamu, Yiminu'er, Jiang, Chaoyu, Sang, Jianfeng, Su, Lei. 2022. MTHFD1L knockdown diminished cells growth in papillary thyroid cancer. In Tissue & cell, 77, 101869. doi:10.1016/j.tice.2022.101869. https://pubmed.ncbi.nlm.nih.gov/35870426/
6. Bryant, Joshua D, Sweeney, Shannon R, Sentandreu, Enrique, Tiziani, Stefano, Appling, Dean R. 2018. Deletion of the neural tube defect-associated gene Mthfd1l disrupts one-carbon and central energy metabolism in mouse embryos. In The Journal of biological chemistry, 293, 5821-5833. doi:10.1074/jbc.RA118.002180. https://pubmed.ncbi.nlm.nih.gov/29483189/
7. Hubacek, J A, Staněk, V, Gebauerová, M, Adámková, V, Pitˇha, J. 2015. Rs6922269 marker at the MTHFD1L gene predict cardiovascular mortality in males after acute coronary syndrome. In Molecular biology reports, 42, 1289-93. doi:10.1007/s11033-015-3870-1. https://pubmed.ncbi.nlm.nih.gov/25809277/